IPO – 7 things to know before Mono Pharmacare Limited


Overview of IPO:

  • Mono Pharmacare Limited ipo : Established in 1994, engaged in pharmaceutical product marketing and distribution.

Product Range:

  • Diverse pharmaceutical products, including:
    • Health Care products
    • Antibiotic medicines
    • Cough Cold Anti Allergic medicines
    • Antifungal medicines
    • Nutraceutical medicines
    • Analgesic & Antipyretic medicines
    • Antacid & Antiemetics medicines
    • Cardiac – Diabetic medicines
    • Cosmocare products

Brand Strategy and Acquisition:

  • Collaboration with contract manufacturers to produce pharmaceuticals under the brand name DLS Export.
  • Acquired DLS Export in 2022 for ₹609 lakhs, expanding product portfolio in specific therapeutic areas.

Distribution Network:

  • Over 168 pharmaceutical companies as distributors and stockists.
  • Served more than 3,036 customers/vendors, encompassing retail pharmacy stores and wholesalers.

Mono Pharmacare IPO Details

  • The Mono Pharmacare IPO is categorized as a Book Built Issue.
  • The total issue size of the IPO is Rs 14.84 Crores.
  • The Mono Pharmacare IPO price range is set at ₹26 to ₹28 per share.
  • The IPO is scheduled to be listed on the NSE SME (National Stock Exchange Small and Medium Enterprises) platform.
IPO DateAug 28, 2023 to Aug 30, 2023
Listing DateThursday, 7 September 2023
Price₹26 to ₹28 per share
Lot Size4000 Shares
Total Issue Size
(aggregating up to ₹14.84 Cr)
Fresh Issue5,300,000 shares
(aggregating up to ₹14.84 Cr)
Share holding pre issue12,368,564
Share holding post issue17,668,564

Mono Pharmacare IPO Timetable (Tentative)

IPO Open DateMonday, 28 August 2023
IPO Close DateWednesday, 30 August 2023
Basis of AllotmentMonday, 4 September 2023
Initiation of RefundsTuesday, 5 September 2023
Credit of Shares to DematWednesday, 6 September 2023
Listing DateThursday, 7 September 2023
Cut-off time for UPI mandate confirmation5 PM on Aug 30, 2023

Key Performance Indicator

Market Cap (₹ Cr.)49.47
EPS (Rs)EPS (Rs)

Mono Pharmacare IPO Lot Size

Retail (Min)14000₹112,000
Retail (Max)14000₹112,000
HNI (Min)28000₹224,000

Mono Pharmacare IPO Promoter Holding

Panilam Lakhatariya and Supal Lakhatariya are the company’s promoters.

Pre Issue Share Holding

Post Issue Share Holding

Financials of the Company:

Period Ended31 Mar 202031 Mar 202131 Mar 202231 Mar 2023
Profit After Tax1.999.5135.0995
Net Worth201.92369.58427.571369
Reserves and Surplus131.71
Total Borrowing633.46608.03643.93
Amount in ₹ Lakhs

Objects of the Issue

  1. Meeting working capital requirements.
  2. General corporate purposes.
  3. Covering the expenses related to the issue.

Mono Pharmacare IPO Review (I May apply according to bidding status)

The company operates as a distributor for several prominent pharmaceutical firms and has demonstrated strong performance during the reported periods. However, considering the robust earnings in FY23, the issue seems to have an aggressive pricing. Savvy investors with good insights might consider investing for potential medium to long-term gains

Mono Pharmacare IPO Subscription Status (Bidding Detail)

As of August 28, 2023, at 7:29 PM, the Mono Pharmacare IPO has been subscribed 1.60 times.

  • The public issue has been subscribed 3.37 times in the retail category.
  • In the Qualified Institutional Buyer (QIB) category, the subscription is 0.00 times.
  • The Non-Institutional Investor (NII) category has been subscribed 0.19 times.

 Check Day by Day Subscription Details (Live Status)

Mono Pharmacare SME IPO GMP

GMP for Mono Pharmacare SME IPO has not started yet. We are updating the GMP information on a daily basis. Please visit us again soon for the latest GMP updates.

check live Gmp details(status)

For more IPO related content like this stay tuned with ipohunts.

for previous financial blog about Sahaj fashions limited click here.

If you are Interested in cricket buzzers and updates then make sure to check out crikzone.


The content provided here should not be interpreted as an invitation or solicitation to buy or sell securities, nor should it be regarded as guidance for such actions. All material presented is intended solely for educational and informational purposes and should not be utilized for making investment choices in any manner. It is imperative to recognize that any data shared here carries no intent to influence investment decisions. Any individual considering investment moves should first seek guidance from a qualified financial advisor, taking into account the particulars of their circumstances.

It is vital to underscore that any decisions based on the information shared here are undertaken at one’s own risk. As with all investments in the stock market, it’s important to acknowledge the inherent and unpredictable risks associated with such endeavors.

2 thoughts on “IPO – 7 things to know before Mono Pharmacare Limited

Leave a Reply

Your email address will not be published. Required fields are marked *